Table 2 Clinical features and severity of SARS-CoV-2 infection of women according to the COVID-19 status during pregnancy or postpartum.
Clinical features and severity | Confirmed COVID-19 n = 289 | Negative COVID-19 n = 270 | p-value |
|---|---|---|---|
Number of days with symptoms before enrolmenta | 0.008 | ||
1–3 | 126 (46.3%) | 159 (59.6%) | |
4–10 | 110 (40.4%) | 88 (33.0%) | |
> 10 | 36 (13.2%) | 20 (7.5%) | |
Multiple testsb | 56 (19.6%) | 98 (36.3%) | < 0.001 |
Tachypnea at admission (> 24 bpm)c | 71 (27.3%) | 43 (18%) | 0.013 |
Desaturation at admission (< 95%)d | 22 (8.2%) | 9 (3.6%) | 0.027 |
Initial managemente | 0.005 | ||
Discharge from ER | 131 (45.5%) | 116 (43.0%) | |
Ward admission | 99 (34.5%) | 108 (40.0%) | |
Labor ward | 30 (10.0%) | 38 (14.0%) | |
ICU admission | 28 (9.7%) | 8 (3.0%) | |
SARSf | 47 (16.3%) | 17 (6.3%) | < 0.001 |
ICU admission at any timef | 48 (16.7%) | 17 (6.3%) | < 0.001 |
Intubationg | 18 (7.2%) | 3 (1.2%) | 0.001# |
Prone positionh | 14 (5.6%) | 0 (0%) | < 0.001# |
Renal impairment (Cr > 1.1)i | 17 (13.2%) | 10 (9.8%) | 0.428 |
Maternal deathj | 13 (4.7%) | 0 (0%) | 0.001# |
Any severe maternal outcome | 62 (21.5%) | 23 (8.5%) | < 0.001 |
